Aquaculture Diagnostics Market Size, Share, Growth, Trends, and Global Industry Analysis: By Technology (Microscopic Examination, Histopathology, Microbiological Examination, Immunodiagnostics, Molecular Diagnostics, Others), By Species Type (Salmon, Sea bass and Sea Bream, Tilapia, Trout, Carp, Crustaceans), By Infection Type (Bacterial Infections, Viral infections, Parasitic Infections, Others), and Region

Aquaculture Diagnostics Market size was valued at US$ 739.8 million in 2023 and is expected to grow at a 9.2% CAGR from 2024 to 2030. The increasing population across the globe and the changing dietary preferences of individuals are expected to drive growth over the forecast period. In addition, rising disease outbreaks in aquaculture animals are expected to propel the growth of the aquaculture diagnostic market.

For instance, In 2023, Salmon farming giant Aqua Chile confirmed an ISA outbreak at a salmon farm. Furthermore, the strict government regulations mandating the monitoring and control of disease outbreaks in aquaculture farms and their rising investments are expected to have a positive impact on the. For instance, in 2019, the Chilean government’s Strategic Investment Fund contributed $16.7 million and the salmon industry’s Salmon Technological Institute another $697,000 to generate knowledge about the main pathogen that threatens the salmon industry.

However, factors such as the high cost associated with the development and commercialization of diagnostic kits, and the lack of skilled professionals are expected to hinder the growth over the forecast years. For instance, A study conducted by the European Aquaculture Technology and Innovation Platform (EATIP) in 2020 found that the shortage of skilled professionals is one of the main barriers to the adoption of new diagnostic technologies in the European aquaculture sector. Moreover, the increasing adoption of molecular diagnostics, such as PCR and Next-Generation Sequencing (NGS), and the development of current and emerging molecular diagnostic technologies are anticipated to provide a tremendous opportunity to the market players in the growth.

Key Developments

• In March 2022, WellFish Diagnostics developed the first non-lethal way of assessing the health of farmed salmon and trout and has landed a £1.2 million investment from the University of the West of Scotland (UWS), Kelvin Capital and Scottish Enterprise.
• In July 2020, Zoetis Acquires Fish Vet Group to Enhance Aquaculture Diagnostic Capabilities.